MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 93 filers reported holding MAGENTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -66.7% | 2,389 | -22.4% | 0.00% | – |
| Q1 2022 | $9,000 | -35.7% | 3,080 | 0.0% | 0.00% | – |
| Q4 2021 | $14,000 | -36.4% | 3,080 | 0.0% | 0.00% | – |
| Q3 2021 | $22,000 | -26.7% | 3,080 | 0.0% | 0.00% | – |
| Q2 2021 | $30,000 | +11.1% | 3,080 | +36.5% | 0.00% | – |
| Q1 2021 | $27,000 | +42.1% | 2,257 | -7.8% | 0.00% | – |
| Q4 2020 | $19,000 | +11.8% | 2,449 | 0.0% | 0.00% | – |
| Q3 2020 | $17,000 | -15.0% | 2,449 | -8.1% | 0.00% | – |
| Q2 2020 | $20,000 | -4.8% | 2,666 | -19.0% | 0.00% | – |
| Q1 2020 | $21,000 | -65.6% | 3,293 | -18.0% | 0.00% | – |
| Q4 2019 | $61,000 | +84.8% | 4,014 | +23.5% | 0.00% | – |
| Q3 2019 | $33,000 | -31.2% | 3,249 | 0.0% | 0.00% | – |
| Q2 2019 | $48,000 | +20.0% | 3,249 | +33.2% | 0.00% | – |
| Q1 2019 | $40,000 | +900.0% | 2,439 | +253.5% | 0.00% | – |
| Q4 2018 | $4,000 | -50.0% | 690 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | – | 690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 6,758,204 | $49,200,000 | 11.16% |
| Aquilo Capital Management, LLC | 3,155,082 | $22,969,000 | 4.17% |
| GREAT POINT PARTNERS LLC | 1,170,000 | $8,518,000 | 1.98% |
| Casdin Capital, LLC | 3,901,589 | $28,404,000 | 0.71% |
| Alphabet Inc. | 3,339,138 | $24,309,000 | 0.58% |
| Bleichroeder LP | 434,400 | $3,162,000 | 0.51% |
| Palo Alto Investors LP | 432,300 | $3,147,000 | 0.19% |
| Integral Health Asset Management, LLC | 90,000 | $655,000 | 0.19% |
| Orbimed Advisors | 1,892,953 | $13,781,000 | 0.15% |
| HARVARD MANAGEMENT CO INC | 332,610 | $2,421,000 | 0.14% |